Advisory Working News Today

“It was not a complete evaluation of the trial, it was not a complete assessment of the clinical program for bamlanivimab, and no contact was made with Lilly seeking additional information prior to its publication.” Bamlanivimab is an antibody drug developed using technology from AbCellera Biologics that allows hundreds of thousands of tests to occur simultaneously to identify a virus protein, in this case COVID-19. The drug was approved for use in the U.S. and Canada last November, and ...

Article content The B.C. Ministry of Health has come under fire for rejecting a COVID-19 drug treatment engineered in Vancouver that has been approved for use by Health Canada. In a prepared statement, U.S. pharmaceutical company Eli Lilly claimed the ministry of health “came to this decision after a limited appraisal of a manuscript from a single phase 2 trial as accepted for publication by the (New England Journal of Medicine.) We apologize, but this video has failed to load. Try refreshing...